American Association of Pharmaceutical Scientists Foundation – AAPS Foundation Online Auction
Auction Ends: Nov 8, 2015 11:59 PM EST

CDs, DVDs & Games

AAPS eCourse of Your Choosing!

Item Number
113
Estimated Value
2239 USD
Opening Bid
400 USD

Item Description

American Association of Pharmaceutical Scientists (AAPS) is offering one eCourse of the bidder's choosing.  To see the current list of AAPS eCourse offered, visit: http://www.aaps.org/eCourses/

 

A special donation from: American Association of Pharmaceutical Scientists (AAPS)

Item Special Note

AAPS eCourses Available:

AAPS' Stability Testing 101 ecourse is designed to provide a basic to advanced level understanding on developing a stability program to support the expiration dating of pharmaceutical products. The speakers will discuss different areas from development to commercial to understand the stability profile of drug substance and drug products. This workshop will also give a thorough update of recent and emerging techniques used to establish the integrity, strength, quality and purity of drug products.


AAPS' Preformulation 101 will explore the fundamental role of formulation scientists- converting candidate drugs into drug products. To achieve this goal it is important to have a thorough understanding of a drug’s pharmaceutical properties. The objective of this course is to provide fundamentals of the preformulation studies and how the physicochemical, physicomechanical, and biopharmaceutical properties data generated during these studies can impact the design, technology, and overall process.

AAPS' Good Oral Candidates 101 will feature case studies and step through the fundamentals of achieving optimal oral exposure. After attending all lectures the participants will have a high level understanding of a multitude of subjects like oral absorption and the impact of phase and formulation design, phase and formulation design, GI physiology, drug metabolism and transporters, in-vitro and in-vivo screening tools, and PBPK-based approaches to model oral absorption.

AAPS’ Translational Sciences 101 features innovative technologies in translational sciences to streamline drug discovery, development, and therapeutics. This is a new and exciting field that will have a significant impact on many facets of pharmaceutical sciences and pharmaceutical care. The promise and potential of this field is reflected in several initiatives, including new institutes and peer-reviewed journals. This eCourse introduces the field of translational sciences to pharmaceutical scientists and pharmacists through state-of-the-art lectures on basic principles, and clear case studies in which these technologies are applied to improve the efficiency of bringing new drugs to patients.

AAPS’ Immunogenicity 101 is a comprehensive online training eCourse that provides an in depth overview of beginning through advanced topics for the assessment and interpretation of immunogenicity. As the field of biologic drug development is maturing, a wealth of knowledge has emerged on the topic of immunogenicity from the disciplines of immunology, bioanalytical sciences, protein manufacturing and formulation, and regulatory sciences.

AAPS’ Regulatory Affairs 101 provides an overview and cross-functional training in regulatory sciences (from the perspective of a pharmaceutical scientist) to better understand current regulatory processes from discovery to commercialization of pharmaceutical products.  Designed with pharmaceutical scientists in mind, the eCourse presents a global outlook on regulatory affairs and how regulations impact the current development process. This is particularly timely given recent expansion of marketing products in emerging markets such as Brazil, Russia, India, and China.

AAPS' first online training course, Biotechnology 101, is a comprehensive online training course developed for those interested in learning more about the field of biologic development. AAPS Biotechnology 101 eLearning series addresses the fact that drug development of biotech products is quite different from that of small molecules, and current biotechnology curricula may lack the practical drug development aspects to prepare students for the biopharmaceutical industry.